These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36013093)
1. A Retrospective Chart Review of Factors Impacting Psychotropic Prescribing Patterns and Polypharmacy Rates in Youth with Autism Spectrum Disorder during the COVID-19 Pandemic. Taniguchi E; Conant K; Keller K; Kim SJ J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013093 [TBL] [Abstract][Full Text] [Related]
2. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015. Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population. Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625 [TBL] [Abstract][Full Text] [Related]
4. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom. Houghton R; Liu C; Bolognani F Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202 [TBL] [Abstract][Full Text] [Related]
5. Prescribed psychotropic medication patterns among treated Foster Care enrollees: a single institution study. Cosme CG; Rudig NO; Borsellino PJ; Chea D; Krider RI; Durette L Front Psychiatry; 2023; 14():1278233. PubMed ID: 38274418 [TBL] [Abstract][Full Text] [Related]
6. Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis. Vohra R; Madhavan S; Sambamoorthi U; StPeter C; Poe S; Dwibedi N; Ajmera M Drugs Real World Outcomes; 2016 Dec; 3(4):409-425. PubMed ID: 27873285 [TBL] [Abstract][Full Text] [Related]
7. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States. Houghton R; Ong RC; Bolognani F Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809 [TBL] [Abstract][Full Text] [Related]
8. Psychotropic Medication Prescribing for Youth at a Regional Autism Center. Gannon S; Abdelrazek A; Keller K; Rockhill C; Kim SJ J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):653-658. PubMed ID: 34242065 [No Abstract] [Full Text] [Related]
9. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. Linden M; Lecrubier Y; Bellantuono C; Benkert O; Kisely S; Simon G J Clin Psychopharmacol; 1999 Apr; 19(2):132-40. PubMed ID: 10211914 [TBL] [Abstract][Full Text] [Related]
10. Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Spencer D; Marshall J; Post B; Kulakodlu M; Newschaffer C; Dennen T; Azocar F; Jain A Pediatrics; 2013 Nov; 132(5):833-40. PubMed ID: 24144704 [TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites. Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917 [TBL] [Abstract][Full Text] [Related]
12. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder. Rast JE; Anderson KA; Roux AM; Shattuck PT Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of Primary Care Providers' Consultations With a Statewide Child Psychiatry Access Program Regarding Autism Spectrum Disorder. Reinblatt SP; Coble K; Williams JL; Cotton AM; Bettencourt AF J Acad Consult Liaison Psychiatry; 2022; 63(5):463-473. PubMed ID: 35085823 [TBL] [Abstract][Full Text] [Related]
14. National trends in psychotropic medication polypharmacy in office-based psychiatry. Mojtabai R; Olfson M Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220 [TBL] [Abstract][Full Text] [Related]
15. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders. Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105 [TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists. Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224 [TBL] [Abstract][Full Text] [Related]
17. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends. Girand HL; Litkowiec S; Sohn M Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590 [TBL] [Abstract][Full Text] [Related]
18. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Jobski K; Höfer J; Hoffmann F; Bachmann C Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381 [TBL] [Abstract][Full Text] [Related]
19. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S Drugs Aging; 2009; 26(6):493-503. PubMed ID: 19591524 [TBL] [Abstract][Full Text] [Related]
20. Trends in GP prescribing of psychotropic medications among young patients aged 16-24 years: a case study analysis. Brijnath B; Xia T; Turner L; Mazza D BMC Psychiatry; 2017 Jun; 17(1):214. PubMed ID: 28587610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]